Stock Comparison
HLN vs TAK
Haleon plc and Takeda Pharmaceutical Co Ltd ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$40.72B
$50.27B
P/E (TTM)
18.9
—
Forward P/E
17.5
10.3
Price/Sales
3.7
0.0
Price/Book
1.9
1.1
EV/EBITDA
13.3
16.9
Dividend Yield
2.09%
4.16%
Profitability
Net Margin
15.10%
-3.38%
Operating Margin
23.20%
11.10%
Return on Equity
10.30%
-2.12%
Return on Assets
4.67%
2.55%
Growth (YoY)
Revenue Growth
0.60%
3.90%
Earnings Growth
92.00%
330.20%
Price & Risk
Beta
0.2
0.1
52-Week High
$11.13
$18.90
52-Week Low
$8.60
$12.78
Analyst Target
$11.69
$20.60
Compare HLN and TAK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.